Clinical Trial Update: Escitalopram Treatment In Acute Stroke [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating escitalopram for acute stroke has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: University of Aarhus | Conditions: Stroke | Phase 4 | Status: WITHDRAWN